Cytokinetics Inc (CYTK) — Financial Flexibility Index
Cytokinetics Inc (CYTK) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-155.51 Million (operating CF $-159.84 Million minus capex $4.33 Million) represents 0% of total liabilities ($2.10 Billion). Check total reinvestment intensity of Cytokinetics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cytokinetics Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Cytokinetics Inc across 24 annual periods. For the full cash flow conversion analysis, see Cytokinetics Inc cash conversion from operations.
Annual Financial Flexibility Index for Cytokinetics Inc (2002–2025)
Year-by-year free cash flow to debt coverage for Cytokinetics Inc. Explore Cytokinetics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-485.20 Million | $-510.01 Million | $2.08 Billion | ▲ +8.7% |
| 2024 | -0.26x | $-391.98 Million | $-395.89 Million | $1.54 Billion | ▲ +25.2% |
| 2023 | -0.34x | $-412.92 Million | $-414.33 Million | $1.21 Billion | ▼ -32.9% |
| 2022 | -0.26x | $-288.18 Million | $-299.52 Million | $1.12 Billion | ▼ -63.8% |
| 2021 | -0.16x | $-93.65 Million | $-142.52 Million | $597.46 Million | ▼ -429.6% |
| 2020 | 0.05x | $20.00 Million | $8.94 Million | $420.42 Million | ▲ +116.2% |
| 2019 | -0.29x | $-88.29 Million | $-90.91 Million | $300.75 Million | ▲ +45.8% |
| 2018 | -0.54x | $-100.33 Million | $-101.22 Million | $185.24 Million | ▼ -1.3% |
| 2017 | -0.53x | $-98.88 Million | $-101.76 Million | $184.97 Million | ▼ -205.0% |
| 2016 | 0.51x | $38.58 Million | $36.98 Million | $75.78 Million | ▲ +336.1% |
| 2015 | 0.12x | $5.45 Million | $4.88 Million | $46.65 Million | ▲ +110.9% |
| 2014 | -1.07x | $-43.74 Million | $-44.84 Million | $40.90 Million | ▼ -328.3% |
| 2013 | -0.25x | $-7.18 Million | $-7.72 Million | $28.75 Million | ▲ +95.4% |
| 2012 | -5.45x | $-33.31 Million | $-33.44 Million | $6.11 Million | ▲ +44.5% |
| 2011 | -9.83x | $-45.15 Million | $-45.59 Million | $4.59 Million | ▼ -65.7% |
| 2010 | -5.93x | $-44.34 Million | $-44.83 Million | $7.48 Million | ▼ -1500.3% |
| 2009 | 0.42x | $8.97 Million | $8.42 Million | $21.17 Million | ▲ +126.3% |
| 2008 | -1.61x | $-60.67 Million | $-61.33 Million | $37.69 Million | ▼ -20096.8% |
| 2007 | -0.01x | $-442.00K | $-3.00 Million | $55.45 Million | ▲ +98.8% |
| 2006 | -0.66x | $-41.80 Million | $-47.17 Million | $63.20 Million | ▲ +68.9% |
| 2005 | -2.12x | $-38.02 Million | $-39.48 Million | $17.90 Million | ▼ -33.7% |
| 2004 | -1.59x | $-32.63 Million | $-34.03 Million | $20.55 Million | ▼ -795.9% |
| 2003 | -0.18x | $-27.46 Million | $-30.51 Million | $154.90 Million | ▼ -31.6% |
| 2002 | -0.13x | $-15.73 Million | $-22.30 Million | $116.76 Million | — |